Aytu BioScience Inc. (AYTU)

[ash111]

Please check Phase 3 companies Valuation. company is trading 50% below cash on hand and will have more $8m cash when need arrives
Company products under the spotlight these days: 

Tesla's Elon Musk works 120 hours a week, uses Ambien to sleep 
https://t.co/RzIzNJCZlP ;

Drugmakers continue price increases: Aytu BioScience recently bought rights to a spray form of Ambien and then raised the price as much as 843% https://t.co/Dkn6PJQ2SS via @WSJ 

" the biggest price increase this month -- of more than 700 percent --came from tiny Aytu BioScience Inc., for an obscure sleep drug called Zolpimist"https://t.co/sSM4gwBgBf ;

CEO ... 

“if we only achieved 5% penetration in each of these markets, that would be approximately $90 to $100M net revenue. A rationally-valued specialty pharma comp would be valued at 3 to 5 times net revenue, so that would approximate a $300M to $500”